Objective: To assess whether indobufen, a reversible inhibitor of platelet cyclooxygenase (Cox) activity, affects tissue factor (TF) in human monocytes and to investigate the relationship between Cox-derived products and TF. Methods: TF was evaluated in isolated adherent monocytes, both resting and lipopolysaccharide (LPS)-stimulated, in terms of procoagulant activity, protein, and mRNA levels. The expression of TF surface antigen was determined in LPS-stimulated whole blood monocytes by flow cytometry. The levels of the stable thromboxane A2 (TxA2) metabolite, TxB2, and of prostaglandin E2 (PGE2) were measured in monocyte supernatant by immunoenzymatic techniques. Cox-1 and Cox-2 protein level, tyrosine phosphorylation, and mitogen-activated protein kinase (MAP-kinase) activation were determined by Western blot analysis. Results: Indobufen prevents TF expression and activity both in isolated and in whole blood monocytes. Reduction of TxA2 synthesis, coupled with a lack of effect on PGE2 levels and prevention of ERK1/2 phosphorylation are highlighted as the mechanisms through which indobufen negatively affects TF. Conclusions: Data show that indobufen down-regulates TF in monocytes. This novel activity, coupled with the antiplatelet effect of the drug, may add benefit for its use in the management of atherothrombosis. © 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.

Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism / S., Eligini; Violi, Francesco; C., Banfi; S. S., Barbieri; M., Brambilla; Saliola, Mirella; E., Tremoli; S., Colli. - In: ATHEROSCLEROSIS SUPPLEMENTS. - ISSN 1567-5688. - 7:1(2006), pp. 391-391. ((Intervento presentato al convegno 14th Meeting of the International-Society-of-Atherosclerosis tenutosi a Rome, ITALY nel JUN 18-22, 2006 [10.1016/j.cardiores.2005.07.013].

Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism

VIOLI, Francesco;SALIOLA, Mirella;
2006

Abstract

Objective: To assess whether indobufen, a reversible inhibitor of platelet cyclooxygenase (Cox) activity, affects tissue factor (TF) in human monocytes and to investigate the relationship between Cox-derived products and TF. Methods: TF was evaluated in isolated adherent monocytes, both resting and lipopolysaccharide (LPS)-stimulated, in terms of procoagulant activity, protein, and mRNA levels. The expression of TF surface antigen was determined in LPS-stimulated whole blood monocytes by flow cytometry. The levels of the stable thromboxane A2 (TxA2) metabolite, TxB2, and of prostaglandin E2 (PGE2) were measured in monocyte supernatant by immunoenzymatic techniques. Cox-1 and Cox-2 protein level, tyrosine phosphorylation, and mitogen-activated protein kinase (MAP-kinase) activation were determined by Western blot analysis. Results: Indobufen prevents TF expression and activity both in isolated and in whole blood monocytes. Reduction of TxA2 synthesis, coupled with a lack of effect on PGE2 levels and prevention of ERK1/2 phosphorylation are highlighted as the mechanisms through which indobufen negatively affects TF. Conclusions: Data show that indobufen down-regulates TF in monocytes. This novel activity, coupled with the antiplatelet effect of the drug, may add benefit for its use in the management of atherothrombosis. © 2005 European Society of Cardiology. Published by Elsevier B.V. All rights reserved.
indobufen; monocytes; thrombosis; thromboxane; tissue factor
01 Pubblicazione su rivista::01a Articolo in rivista
Indobufen inhibits tissue factor in human monocytes through a thromboxane-mediated mechanism / S., Eligini; Violi, Francesco; C., Banfi; S. S., Barbieri; M., Brambilla; Saliola, Mirella; E., Tremoli; S., Colli. - In: ATHEROSCLEROSIS SUPPLEMENTS. - ISSN 1567-5688. - 7:1(2006), pp. 391-391. ((Intervento presentato al convegno 14th Meeting of the International-Society-of-Atherosclerosis tenutosi a Rome, ITALY nel JUN 18-22, 2006 [10.1016/j.cardiores.2005.07.013].
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/24916
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 0
social impact